Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, June 5, 2026

Early Bobath-Based Neurorehabilitation After Mechanical Thrombectomy for Moderate-to-Severe Hemiparesis: Preliminary Findings From a Propensity Score–Matched Cohort Study

Everyone here is so incompetent that they missed that Bobath should have been shitcanned since 2003!

Who still uses NDT(Bobath) in stroke rehab when it should have been shitcanned since 2003? Physiotherapy Based on the Bobath Concept for Adults with Post-Stroke Hemiplegia: A Review of Effectiveness Studies 2003))

The latest incompetent shit here: 

Early Bobath-Based Neurorehabilitation After Mechanical Thrombectomy for Moderate-to-Severe Hemiparesis: Preliminary Findings From a Propensity Score–Matched Cohort Study


Received 16 Mar 2026, Accepted 27 May 2026, Accepted author version posted online: 02 Jun 2026
Cite this article
  • https://doi.org/10.1080/00207454.2026.2682964
  •  

    Abstract

     Background 
    Motor impairment is a determinant of long-term disability after acute ischemic stroke (AIS), even in patients achieving reperfusion through mechanical thrombectomy. However, evidence regarding rehabilitation after thrombectomy, particularly for patients with moderate-to-severe hemiparesis, remains limited.
    Methods 
    We conducted a single-center retrospective propensity score–matched cohort study comparing early Bobath-based neurorehabilitation with conventional rehabilitation in AIS patients with moderate-to-severe hemiparesis after anterior-circulation mechanical thrombectomy. Patients aged ≥18 years initiated rehabilitation within 30 days after the procedure, and complete discharge and follow-up data were required for inclusion in the matched cohort. The primary outcome was change in Fugl–Meyer Assessment (FMA) motor score from baseline to discharge. Secondary outcomes included Modified Barthel Index (MBI), Modified Ashworth Scale (MAS), modified Rankin Scale (mRS), quality of life, and safety outcomes during 12-month follow-up.
    Results 
    After matching, 206 patients (103 per group) were included. At discharge, the Bobath group showed greater improvement in motor function and daily living ability than the conventional group (adjusted mean difference: FMA 5.7 points, 95% CI 3.4–8.0; MBI 6.6 points, 95% CI 4.0–9.3; both P < 0.001). Improvements remained significant at 3 months but not at 12 months. Functional independence (mRS ≤2) at 3 months was more frequent in the Bobath group (82.5% vs 73.8%; P = 0.05). Complication rates were similar between groups.
    Conclusions 
    Early Bobath-based neurorehabilitation is associated with better short-term motor and functional recovery without increased adverse events after mechanical thrombectomy. The between-group differences attenuated by 12 months; therefore, further multicenter prospective studies are needed to confirm durability and long-term benefit.

    No comments:

    Post a Comment